标题
Integrated Dataset of Screening Hits against Multiple Neglected Disease Pathogens
作者
关键词
-
出版物
PLoS Neglected Tropical Diseases
Volume 5, Issue 12, Pages e1412
出版商
Public Library of Science (PLoS)
发表日期
2011-12-21
DOI
10.1371/journal.pntd.0001412
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
- (2011) S. A. Charman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Innovative Partnerships for Drug Discovery against Neglected Diseases
- (2011) Palle H. Jakobsen et al. PLoS Neglected Tropical Diseases
- Discovery of Potent Small-Molecule Inhibitors of Multidrug-Resistant Plasmodium falciparum Using a Novel Miniaturized High-Throughput Luciferase-Based Assay
- (2010) E. Lucumi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Image-Based High-Throughput Drug Screening Targeting the Intracellular Stage of Trypanosoma cruzi, the Agent of Chagas' Disease
- (2010) J. C. Engel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India
- (2010) Henry W Murray Future Microbiology
- Analysis and hit filtering of a very large library of compounds screened against Mycobacterium tuberculosis
- (2010) Sean Ekins et al. Molecular BioSystems
- Thousands of chemical starting points for antimalarial lead identification
- (2010) Francisco-Javier Gamo et al. NATURE
- Chemical genetics of Plasmodium falciparum
- (2010) W. Armand Guiguemde et al. NATURE
- In Vitro activities of plant extracts from Saudi Arabia against malaria, leishmaniasis, sleeping sickness and Chagas disease
- (2010) Essam Abdel-Sattar et al. PHYTOTHERAPY RESEARCH
- Spiroindolones, a Potent Compound Class for the Treatment of Malaria
- (2010) M. Rottmann et al. SCIENCE
- Developing ANDI: A Novel Approach to Health Product R&D in Africa
- (2010) Solomon Nwaka et al. PLOS MEDICINE
- Identification of Attractive Drug Targets in Neglected-Disease Pathogens Using an In Silico Approach
- (2010) Gregory J. Crowther et al. PLoS Neglected Tropical Diseases
- Comparison of Microscopy and Alamar Blue Reduction in a Larval Based Assay for Schistosome Drug Screening
- (2010) Nuha R. Mansour et al. PLoS Neglected Tropical Diseases
- Unresolved issues in anthelmintic pharmacology for helminthiases of humans
- (2009) Timothy G. Geary et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Screening Rules for Leads of Fungicides, Herbicides, and Insecticides†
- (2009) Bin Liu et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Screening of Agelasine D and Analogs for Inhibitory Activity against Pathogenic Protozoa; Identification of Hits for Visceral Leishmaniasis and Chagas Disease
- (2009) Anders Vik et al. MOLECULES
- Advancing Drug Innovation for Neglected Diseases—Criteria for Lead Progression
- (2009) Solomon Nwaka et al. PLoS Neglected Tropical Diseases
- Recent initiatives and strategies to developing new drugs for tropical parasitic diseases
- (2008) Conor R Caffrey et al. Expert Opinion on Drug Discovery
- In vitro anti-microbial activity of the Cuban medicinal plants Simarouba glauca DC, Melaleuca leucadendron L and Artemisia absinthium L
- (2008) Aymé Fernández-Calienes Valdés et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Identification of oxadiazoles as new drug leads for the control of schistosomiasis
- (2008) Ahmed A Sayed et al. NATURE MEDICINE
- Genomic-scale prioritization of drug targets: the TDR Targets database
- (2008) Fernán Agüero et al. NATURE REVIEWS DRUG DISCOVERY
- In silicoactivity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
- (2008) David Plouffe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More